Menu
GeneBe

PDSS1

decaprenyl diphosphate synthase subunit 1

Basic information

Region (hg38): 10:26697700-26746798

Previous symbols: [ "TPRT" ]

Links

ENSG00000148459NCBI:23590OMIM:607429HGNC:17759Uniprot:Q5T2R2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Strong), mode of inheritance: AR
  • deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Moderate), mode of inheritance: AR
  • deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Supportive), mode of inheritance: AR
  • deafness-encephaloneuropathy-obesity-valvulopathy syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Coenzyme Q10 deficiency 2ARBiochemicalThere can be a wide range of manifestations, and in some individuals, treatment with Coenzyme Q10 supplementation can be beneficialAudiologic/Otolaryngologic; Biochemical; Cardiovascular; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Renal17332895; 22231380

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDSS1 gene.

  • not provided (242 variants)
  • Deafness-encephaloneuropathy-obesity-valvulopathy syndrome (61 variants)
  • not specified (23 variants)
  • Inborn genetic diseases (13 variants)
  • Coenzyme Q10 deficiency (3 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDSS1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
44
clinvar
44
missense
83
clinvar
2
clinvar
2
clinvar
87
nonsense
1
clinvar
4
clinvar
5
start loss
0
frameshift
2
clinvar
1
clinvar
4
clinvar
7
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
0
splice region
1
10
9
1
21
non coding
7
clinvar
31
clinvar
49
clinvar
87
Total 2 2 101 77 51

Highest pathogenic variant AF is 0.0000132

Variants in PDSS1

This is a list of pathogenic ClinVar variants found in the PDSS1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-26697729-G-A Likely pathogenic (Jan 03, 2023)1878854
10-26697745-T-C Uncertain significance (Sep 13, 2022)2025123
10-26697745-T-G Inborn genetic diseases Uncertain significance (Sep 14, 2022)2384655
10-26697746-G-A Inborn genetic diseases Uncertain significance (Oct 06, 2022)2317406
10-26697752-G-C Uncertain significance (Apr 23, 2022)1899554
10-26697753-G-C Uncertain significance (Jun 02, 2021)1206944
10-26697758-C-T Uncertain significance (Mar 24, 2022)1706980
10-26697762-G-A Deafness-encephaloneuropathy-obesity-valvulopathy syndrome Conflicting classifications of pathogenicity (Jul 17, 2023)299691
10-26697764-C-G Uncertain significance (Jun 27, 2022)1504388
10-26697767-G-A Inborn genetic diseases Uncertain significance (Oct 26, 2021)2257069
10-26697771-C-T Likely benign (Sep 11, 2023)3000831
10-26697780-C-G Likely benign (Jan 01, 2023)2640367
10-26697780-C-T Likely benign (Jun 03, 2023)2991307
10-26697781-G-C Deafness-encephaloneuropathy-obesity-valvulopathy syndrome • Inborn genetic diseases Uncertain significance (Jul 19, 2022)1364494
10-26697785-C-T not specified Conflicting classifications of pathogenicity (Nov 01, 2022)214980
10-26697788-C-T Uncertain significance (Nov 01, 2021)1335035
10-26697789-C-A Likely benign (Nov 07, 2023)2996177
10-26697789-C-G Likely benign (Feb 20, 2022)1941424
10-26697793-CG-GC Uncertain significance (May 27, 2022)1924613
10-26697794-G-A Uncertain significance (Aug 10, 2023)1957611
10-26697794-G-T Deafness-encephaloneuropathy-obesity-valvulopathy syndrome Uncertain significance (May 24, 2022)299692
10-26697800-G-C Uncertain significance (Mar 18, 2022)1687674
10-26697800-G-T not specified • Deafness-encephaloneuropathy-obesity-valvulopathy syndrome Benign (Jan 30, 2024)138687
10-26697805-T-A Deafness-encephaloneuropathy-obesity-valvulopathy syndrome Uncertain significance (Aug 30, 2018)1033284
10-26697805-T-G Inborn genetic diseases Uncertain significance (Apr 22, 2021)2229045

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDSS1protein_codingprotein_codingENST00000376215 1249140
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.24e-80.9291257040441257480.000175
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.321612150.7470.00001242674
Missense in Polyphen5082.510.605981024
Synonymous0.7666977.60.8890.00000476809
Loss of Function1.851626.20.6110.00000177285

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003510.000351
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001090.000109
Finnish0.0001850.000185
European (Non-Finnish)0.0002110.000211
Middle Eastern0.0001090.000109
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Supplies decaprenyl diphosphate, the precursor for the side chain of the isoprenoid quinones ubiquinone-10. {ECO:0000269|PubMed:16262699}.;
Disease
DISEASE: Coenzyme Q10 deficiency, primary, 2 (COQ10D2) [MIM:614651]: An autosomal recessive multisystem disorder characterized by early-onset deafness, optic atrophy, mild mental retardation, peripheral neuropathy, obesity, livedo reticularis, and cardiac valvulopathy. {ECO:0000269|PubMed:17332895}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Terpenoid backbone biosynthesis - Homo sapiens (human);Metabolism;Ubiquinol biosynthesis;Metabolism of cofactors;Metabolism of vitamins and cofactors;ubiquinol-10 biosynthesis (Consensus)

Recessive Scores

pRec
0.290

Intolerance Scores

loftool
0.385
rvis_EVS
0.06
rvis_percentile_EVS
58.53

Haploinsufficiency Scores

pHI
0.513
hipred
Y
hipred_score
0.527
ghis
0.576

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
N
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.136

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pdss1
Phenotype

Gene ontology

Biological process
ubiquinone biosynthetic process;isoprenoid biosynthetic process;protein heterotetramerization
Cellular component
mitochondrial matrix;transferase complex
Molecular function
trans-hexaprenyltranstransferase activity;metal ion binding;protein heterodimerization activity;trans-octaprenyltranstransferase activity